Positive inotropic agents: a double-edged sword for chronic heart failure.
Asanoi
H
H
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University.
Inoue
H
H
D002316:Cardiotonic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011719:Pyrazines; D011724:Pyridazines / Q000008:administration & dosage / Q000009:adverse effects; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects
D002316:Cardiotonic Agents; D011719:Pyrazines; D011724:Pyridazines; D011804:Quinolines; C041648:pimobendan; C041667:vesnarinone